Autori: Mrsic-Krmpotic Zrinka
| Naslov | FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study (Article) |
| Autori | Brodowicz Thomas Ciuleanu Tudor E Radosavljevic Davorin Z Shacham-Shmueli Einat Vrbanec Damir Plate Signe Mrsic-Krmpotic Zrinka Dank M Purkalne Gunta Messinger D Zielinski Christoph |
| Info | ANNALS OF ONCOLOGY, (2013), vol. 24 br. 7, str. 1769-1777 |
| Projekat | CECOG |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
     |
| Naslov | Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial (Article) |
| Autori | Jassem Jacek Pienkowski Tadeusz Pluzanska Anna Jelic Svetislav B Gorbunova Vera Mrsic-Krmpotic Zrinka Berzins Juris Nagykalnai Thomas Wigler N Renard J Munier Stephane Weil C |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2001), vol. 19 br. 6, str. 1707-1715 |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
|
